Delta 9 Cannabis Inc.
DLTNF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.09 | -0.00 | 0.04 |
| FCF Yield | -1.11% | 22.04% | 7.20% | 17.88% |
| EV / EBITDA | -60.47 | -35.71 | -30.78 | -56.13 |
| Quality | ||||
| ROIC | -5.34% | -9.20% | -6.76% | -4.94% |
| Gross Margin | 27.04% | -8.70% | 14.77% | 19.90% |
| Cash Conversion Ratio | 0.02 | -0.21 | -0.13 | -1.02 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.71% | 4.49% | 6.25% | 6.11% |
| Free Cash Flow Growth | -107.56% | 104.39% | -69.66% | 423.48% |
| Safety | ||||
| Net Debt / EBITDA | -53.19 | -32.68 | -27.07 | -47.46 |
| Interest Coverage | -1.80 | -2.72 | -2.87 | -2.24 |
| Efficiency | ||||
| Inventory Turnover | 0.98 | 1.57 | 1.01 | 0.77 |
| Cash Conversion Cycle | 81.78 | 54.39 | 84.71 | 112.66 |